The company has developed over 1,400 algorithms, which help identify waste, fraud and abuse in the Medicare, Medicaid, and commercial health insurance segments. LifeWallet offerings include LifeWallet EHR for hospitals and medical providers, Chase to Pay for point-of-care payer identification, and LifeChain for patient-centric data analysis, with additional applications under development. The company's strength lies in its massive assignor network and legal expertise in Medicare Secondary Payer Act litigation.
Cyborg Score Rationale
MSP Recovery exhibits high-risk/high-reward characteristics. The company's revenue increased 136% to $18.2 million in 2024, up from $7.7 million in 2023. However, notable concerns include a going concern warning and a $752.7 million non-cash impairment charge. The restructuring with Virage Capital provides stabilization but reflects prior financial distress.
Top Insights
Recent debt restructuring with Virage Capital and Hazel Partners featured a $9.75 million bridge funding and $144 million debt-to-equity conversion, with settlements exceeding $8 million in pharmaceutical litigation and $10 million from property & casualty insurers.
Virage Capital owns 43% of the company after forgiving $1.2 billion in debt, and MSPR has launched a massive legal campaign against over 350 insurers related to Medicare Secondary Payer Act claims.
The core claims-recovery business is high-leverage; historical announcements referenced billions in paid amounts for billed claims, representing significant monetization potential.
Removal of $1.2 billion of corporate-guaranteed debt under the restructuring term sheet could relieve a major investor overhang if the deal closes as scheduled.
Named Competitors
WageWorks — Healthcare benefits and FSA administration
CVS Aetna — Integrated health insurance and pharmacy services
UnitedHealth Claims Services — Healthcare claims processing and recovery
Recent Developments
(2024) Revenue growth of 136% to $18.2 million; major debt restructuring with Virage Capital and Hazel Partners including $144 million debt-to-equity conversion
(April 2025) Restructuring transaction closing expected to reduce over $1.2 billion in corporate guaranteed debt and extend debt obligations to November 2026
(August 2025) First trial against USAA scheduled regarding Medicare Secondary Payer Act claims; company maintains class certification and deep discovery progress
Open the full interactive MSP Recovery, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.